Ethtry Secratary

Igraine Plc – Fixit Medical Ltd Receipt of Grant from Innovate UK PR Newswire THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION…

Igraine Plc – Financial Statements to 31 December 2023 PR Newswire Financial Statements for the Year Ended 31 December 2023 Igraine Plc (“Igraine” or “the Company”) Financial Statements for the Year Ended 31 December 2023 The directors present their strategic report for the year ended 31 December 2023. PRINCIPAL ACTIVITIES…

Igraine Plc – Fixit Medical Ltd Year End Update PR Newswire THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE (“RIS”), THIS…

Igraine Plc – Holding(s) in Company PR Newswire Igraine plc (AQSE:KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, has received 2 TR-1 Forms, which are reproduced without amendment below. TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR…

Igraine Plc – Final Results PR Newswire 30 June 2023 Igraine Plc AQSE: KING (“Igraine” or “the Company”) Audited Financial Statements for the Year Ended 31 December 2022 The full audited annual report can be found on the Company’s website https://igraineplc.com. REVIEW OF BUSINESS The Directors have been successful in…

Igraine Plc – Investment in Fixit Medical Ltd PR Newswire THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED (“MAR”). ON THE PUBLICATION OF THIS ANNOUNCEMENT  VIA A REGULATORY INFORMATION SERVICE (“RIS”), THIS…